Eli Lilly and Company (ETR:LLY)
698.80
+21.80 (3.22%)
Jun 10, 2025, 5:30 PM CET
Eli Lilly and Company Revenue
Eli Lilly and Company had revenue of $12.73B USD in the quarter ending March 31, 2025, with 45.17% growth. This brings the company's revenue in the last twelve months to $49.00B, up 36.38% year-over-year. In the year 2024, Eli Lilly and Company had annual revenue of $45.04B with 32.00% growth.
Revenue (ttm)
$49.00B
Revenue Growth
+36.38%
P/S Ratio
13.42
Revenue / Employee
$1.04M
Employees
47,000
Market Cap
608.32B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 45.04B | 10.92B | 32.00% |
Dec 31, 2023 | 34.12B | 5.58B | 19.56% |
Dec 31, 2022 | 28.54B | 223.00M | 0.79% |
Dec 31, 2021 | 28.32B | 3.78B | 15.40% |
Dec 31, 2020 | 24.54B | 2.22B | 9.95% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Siemens Healthineers AG | 23.14B |
Merck KGaA | 21.32B |
Bayer Aktiengesellschaft | 46.58B |
Fresenius SE & Co. KGaA | 22.13B |
Fresenius Medical Care AG | 19.49B |
Sartorius Aktiengesellschaft | 3.44B |
Carl Zeiss Meditec AG | 2.17B |
Fielmann Group AG | 2.33B |
Eli Lilly and Company News
- 1 day ago - Visa, Eli Lilly or Netflix— Which Stock Will Be A Trillion Dollar Company Next? - 24/7 Wall street
- 1 day ago - 20 stocks of companies that have improved profit margins and are expected to grow quickly - Market Watch
- 1 day ago - Eli Lilly's Obesity Drug Success Spurs Japanese Biotech's Anti-Muscle-Wasting Combo Therapy - Benzinga
- 2 days ago - Biotech behind Eli Lilly obesity pill aims for new standard of care - Financial Times
- 3 days ago - Eli Lilly is said to have posted 60% rise in obesity drug sales in India last month - Seeking Alpha
- 4 days ago - Healthcare companies are hiring. Is it time to look for growth stocks in this beaten-down sector? - Market Watch
- 4 days ago - Rare Outflow Signals Hit Eli Lilly Shares - FX Empire
- 5 days ago - Eli Lilly: If You Don't Buy On Weight Loss Promise Now, You Probably Never Will - Seeking Alpha